News
Congratulations to the OSBP Awardees at the 2026 CMBP T32 / Center for RNA Biology Annual Symposium
Congratulations to the following OSBP students who won poster awards during the May 2026 CMBP T32/Center for RNA Biology Annual Symposium!
Thaanya Amarasekara
Advisor:…
Congratulations to the OSBP Awardees at the 2026 Molecular Biophysics Training Program Symposium
Congratulations to the following OSBP students who won oral presentation awards during the May 2026 MBTP T32 Symposium!
James Alltop
Advisor: Vladislav Belyy
Congratulations to the OSBP Awardees at the 2026 IGP Symposium
Congratulations to the following OSBP students who won awards during the 2026 IGP Symposium!
Hannah Sanders
Advisor: Kedryn Baskin
Plenary Speaker
Congratulations to the 2026 OSBP PhD Graduates
We are proud to celebrate the following OSBP PhD students on this major milestone and wish them continued success in their next endeavors!
Ruo-Wen (Blanche) Chen
Advisor:…
DHLRI Research Day Predoctoral Poster Competition Winner
Yujia Xie, OSBP doctoral candidate in the Lewandowski lab, received the first prize in the predoctoral poster competition during the OSU Davis Heart and Lung Research Institute (DHLRI) Research…
NIH Awards R21 Grant for Recombinase Engineering Project Developed by OSBP Graduate Student Matthew Benedek
The NIH has awarded a two-year Exploratory/Developmental Grant (R21), titled "Development of Tools for Directed Evolution of High-Specificity, High-Efficiency Recombinases," for a project proposed…
Graduate Student Research Award
Congratulations to Joseph Kanlong for being the first OSBP Graduate Student Research Awardee of 2025!
2025 LS-IGP Student Award Winners
On May 21, the annual Life Sciences Interdisciplinary Graduate Program Symposium convened at The Ohio State University’s Ohio Union. The symposium highlights the research of the four…
The Science Sparking American Growth 2025
City Therapeutics, a company co-founded by Dr. Kotaro Nakanishi, was recognized by The Science Coalition as the Science Sparking American Growth 2025. They are developing next…